
FRANKFURT, March 5 (Reuters) - A German court in Duesseldorf on Wednesday ruled that Pfizer PFE.N and its partner BioNTech 22UAy.DE violated a COVID-19 vaccine patent held by Moderna MRNA.O.
In a statement, the court said that Pfizer and BioNTech would have to provide information on earnings derived from the use of the patent and that they owe Moderna appropriate compensation, though the ruling can still be appealed to a higher court.